Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Kiniksa Pharmaceuticals International (KNSA) over the last 7 years, with Dec 2024 value amounting to $72.2 million.

  • Kiniksa Pharmaceuticals International's Shares Outstanding (Weighted Average) rose 4.02% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.1 million, marking a year-over-year increase of 4.02%. This contributed to the annual value of $72.2 million for FY2024, which is 2.65% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Shares Outstanding (Weighted Average) of $72.2 million as of FY2024, which was up 2.65% from $70.3 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Shares Outstanding (Weighted Average) registered a high of $72.2 million during FY2024, and its lowest value of $68.1 million during FY2020.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Shares Outstanding (Weighted Average) value was $70.3 million (recorded in 2023), while the average stood at $70.7 million.
  • Data for Kiniksa Pharmaceuticals International's Shares Outstanding (Weighted Average) shows a peak YoY rose of 22.55% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Kiniksa Pharmaceuticals International's Shares Outstanding (Weighted Average) stood at $68.1 million in 2020, then increased by 1.19% to $68.9 million in 2021, then increased by 0.93% to $69.5 million in 2022, then climbed by 1.16% to $70.3 million in 2023, then rose by 2.65% to $72.2 million in 2024.